50-year-old male with known syndrome


View content online at: http://www.appliedradiology.com/Quiz-Result-Data/50-year-old-male-with-known-syndrome.aspx

Abstract:  50-year-old male with known syndrome received numerous examinations over a several year period at our institution. The patient’s cirrhosis is considered to be unrelated to his syndrome.

Loading...
Diagnosis

Cowden-Lhermitte-Duclos Syndrome

Findings

Grayscale ultrasound images of the testicles demonstrate numerous bilateral hyperechoic lesions without shadowing. No dominant mass is seen. Fluid within the scrotum on cine images is secondary to ascites.

Contrast-enhanced computed tomography (CT) images of the abdomen demonstrate extensive fat-containing lesions throughout the small bowel. As mentioned in the summary, the findings of cirrhosis and ascites are considered unrelated to the patient’s known syndrome.

T2-weighted coronal and T1-weighted postcontrast axial images demonstrate a T2-hyperintense, nonenhancing lesion within the right cerebellar hemisphere with a striated appearance. The surrounding cerebellar parenchyma is normal in appearance.

Discussion

Cowden-Lhermitte Duclos (COLD) Syndrome is subset of Cowden Syndrome, in which patients also have Lhermitte Duclos Disease (LDD). LDD is characterized by the presence of a benign dysplastic cerebellar gangliocytoma. Cowden Syndrome is also known as Multiple Hamartoma Syndrome.

COLD Syndrome is now thought to represent a new phakomatosis and represent a neurological manifestation of Cowden Syndrome. It displays an autosomal dominant inheritance pattern with variable penetrance, and is caused predominantly (80%) by a mutation in the PTEN tumor suppressor gene.

The clinical manifestations are extremely diverse, affecting nearly any organ system. The most common manifestation is the development of mucocutaneous lesions, such as tricholemmomas and papillomas in 90% of patients. These lesions are detectable by physical examination and should raise suspicion, particularly in patients with a family history. Other common manifestations include breast abnormalities, such as fibrocystic changes, ductal hyperplasia, and intraductal papillomas in 75%, thyroid lesions, such as adenomas and multinodular goiter in 50% to 70%, gastrointestinal polyps in 70%, macrocephaly in 70%, and less commonly genitourinary abnormalities, such as ovarian cysts and uterine leiomyomas. Most importantly, patients are at significantly increased risk for the development of cancer, most commonly involving the breast, thyroid, endometrium, and kidneys. The patient in this case developed a cystic renal cell carcinoma, seen as an indeterminate, hypodense contour abnormality along the midpole of the left kidney on this noncontrasted examination. The presence of fat containing hamartomas within the testicles is a rare finding.

When Lhermitte-Duclose Disease is diagnosed, approximately 50% of patients will also be found to have manifestations of Cowden Syndrome, and the diagnosis of COLD Syndrome can be made. Lhermitte-Duclose Disease is found exclusively within the cerebellum and is indeterminate in etiology, possibly representing a neoplasm, hamartoma, or malformative lesion. The lesions may be symptomatic and necessitate resection if they become large, but are otherwise benign.

  1. Derrey S, Proust F, Debono B, et al. Association between Cowden syndrome and Lhermitte-Duclos disease: report of two cases and review of the literature. Surg Neurol. 2004;61:447-454, discussion 454.
  2. Hauser H, Ody B, Plojoux O, et al. Radiological findings in multiple hamartoma syndrome (Cowden disease): A report of three cases. Radiology. 1980;137:317-323.
  3. Robinson S, Cowen AR. Cowden Disease and Lhermitte-Duclos Disease: Characterization of a new phakomatosis. Neurosurgery. 2000;46:371-383.
  4. Lindsay C, Boardman L, Farrell M. Testicular hamartomas in Cowden Disease. J Clin Ultrasound. 2003;31:481-483.

Tables & Figures

  • Figure 1.
    Figure 1.
  • Figure 2.
    Figure 2.
  • Figure 3.
    Figure 3.
  • Figure 4.
    Figure 4.
  • Figure 5.
    Figure 5.
  • Figure 6.
    Figure 6.